Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,890 | -175,850 | -38,988 | -24,067 | -30,910 |
| Depreciation Amortization | 2,052 | 1,987 | 1,958 | 1,964 | 1,963 |
| Accounts receivable | -28,208 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,612 | 5,672 | 1,372 | -1,477 | -235 |
| Other Working Capital | -24,633 | 6,018 | 2,928 | -756 | -1,148 |
| Other Operating Activity | 73,085 | 93,077 | 7,790 | 3,555 | 2,560 |
| Operating Cash Flow | $46,798 | $-69,096 | $-24,940 | $-20,781 | $-27,770 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -218 | N/A | -13 | -22 |
| Purchase Of Investment | -455,776 | -356,464 | N/A | N/A | N/A |
| Sale Of Investment | 254,068 | 131,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-201,781 | $-225,682 | $N/A | $-13 | $-22 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 238,110 | 213,025 | 180,019 | 14,108 | 0 |
| Common Stock Repurchased | -100,146 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -803 | 0 | 0 | -16 | -128 |
| Financing Cash Flow | $137,161 | $213,025 | $180,019 | $14,092 | $-128 |
| Beginning Cash Position | 87,928 | 169,681 | 14,602 | 21,304 | 49,224 |
| End Cash Position | 70,106 | 87,928 | 169,681 | 14,602 | 21,304 |
| Net Cash Flow | $-17,822 | $-81,753 | $155,079 | $-6,702 | $-27,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,798 | -69,096 | -24,940 | -20,781 | -27,770 |
| Capital Expenditure | -73 | -218 | N/A | -13 | -22 |
| Free Cash Flow | 46,725 | -69,314 | -24,940 | -20,794 | -27,792 |